| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/2007 | US7201899 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/10/2007 | US7201893 Stabilization of UV-sensitive active ingredients |
| 04/10/2007 | US7201765 Method and apparatus for acne treatment |
| 04/10/2007 | US7201751 Supplemental spine fixation device |
| 04/10/2007 | US7201289 Method for introducing a catalyst solution into a coating formulation |
| 04/10/2007 | CA2470066C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2406783C Skin whiteners containing hydroxytetronic acid |
| 04/10/2007 | CA2403869C Method for treating dry eye |
| 04/10/2007 | CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 04/10/2007 | CA2379270C External preparation for skin diseases containing nitroimidazole |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2377746C N-pyrazole a2a receptor agonists |
| 04/10/2007 | CA2377676C Nutritional composition for weight management |
| 04/10/2007 | CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2362931C Novel sulforhamnosylacylglycerol derivatives and use thereof as medicaments |
| 04/10/2007 | CA2337991C Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/10/2007 | CA2337269C Novel method for preparing synthesis intermediates |
| 04/10/2007 | CA2336380C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 04/10/2007 | CA2333985C Testosterone derivative |
| 04/10/2007 | CA2321969C Process for the production of encased, spherical granular grains |
| 04/10/2007 | CA2315293C Progesterone tablet and preparation method |
| 04/10/2007 | CA2314848C Process for preparing beadlets containing fat-soluble substances |
| 04/10/2007 | CA2307068C Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2297924C Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 04/10/2007 | CA2287476C Conjugated linolenic acid-based synthetic triglycerides |
| 04/10/2007 | CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 04/10/2007 | CA2269807C Substituted aminoalkanephosphonic acids |
| 04/10/2007 | CA2258601C Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
| 04/10/2007 | CA2255842C Rosacea treating agent |
| 04/10/2007 | CA2251944C Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 04/10/2007 | CA2242382C Compositions and methods for mediating cell cycle progression |
| 04/10/2007 | CA2237747C New process for the preparation of azithromycin |
| 04/10/2007 | CA2226880C Cyclosporin derivatives with anti-hiv effect |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/10/2007 | CA2202170C Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/10/2007 | CA2199844C Compositions for the treatment of skin disorders |
| 04/10/2007 | CA2198240C Topical ketoconazole emulsions |
| 04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
| 04/10/2007 | CA2189424C Non-steroidal anti-inflammatory ophthalmic suspensions |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |
| 04/10/2007 | CA2167970C Transdermal drug delivery device containing a desiccant |
| 04/10/2007 | CA2164276C New highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 04/10/2007 | CA2162306C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha. lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
| 04/10/2007 | CA2153937C Tricyclic pyrazole derivatives |
| 04/10/2007 | CA2145093C Therapeutic inhibitor of vascular smooth muscle cells |
| 04/10/2007 | CA2135608C Contraception using competitive progesterone antagonists, and novel compounds useful therefor |
| 04/10/2007 | CA2127084C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-ht1a-antagonistic activity |
| 04/10/2007 | CA2116810C Utilization of 6,6-dimethyl-2-acylcyclohex-4-en-1,3-diones derivatives in the suntan protection domain of cosmetics, compositions containing same, novel derivative and process forits production |
| 04/10/2007 | CA2104148C Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of n,n'-substituted ureas |
| 04/06/2007 | CA2522632A1 Ccr5 receptor antagonist molecules |
| 04/05/2007 | WO2007038802A2 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom |
| 04/05/2007 | WO2007038796A1 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| 04/05/2007 | WO2007038785A1 Sulfatides for treatment of autoimmune disorders |
| 04/05/2007 | WO2007038772A1 Novel drugs for dementia |
| 04/05/2007 | WO2007038687A2 Ocular administration of immunosuppressive agents |
| 04/05/2007 | WO2007038684A2 Pyrrole derivatives as therapeutic compounds |
| 04/05/2007 | WO2007038677A2 Methods for preparation of ladostigil tartrate crystalline form a1 |
| 04/05/2007 | WO2007038675A2 Pharmaceutical compositions for treating or preventing migraines |
| 04/05/2007 | WO2007038669A2 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 04/05/2007 | WO2007038648A1 Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester |
| 04/05/2007 | WO2007038636A2 Estriol therapy for autoimmune and neurodegenerataive diseases and disorders |
| 04/05/2007 | WO2007038630A2 N-benzyl substituted pyridyl porphyrin compounds and methods of use thereof |
| 04/05/2007 | WO2007038620A2 Milnacipran for the long-term treatment of fibromyalgia syndrome |
| 04/05/2007 | WO2007038613A2 Selective serine/threonine kinase inhibitors |
| 04/05/2007 | WO2007038596A2 Phytosterol nutritional supplements |
| 04/05/2007 | WO2007038571A2 Prolyl hydroxylase antagonists |
| 04/05/2007 | WO2007038551A2 Use of ibudilast for treating drug and behavioral addictions |
| 04/05/2007 | WO2007038549A1 Treatment of inflammation and vascular abnormalities of the eye |
| 04/05/2007 | WO2007038524A2 Cocrystallization methods |
| 04/05/2007 | WO2007038519A1 Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 04/05/2007 | WO2007038512A2 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals |
| 04/05/2007 | WO2007038507A2 Modified 4'-nucleosides as antiviral agents |
| 04/05/2007 | WO2007038453A2 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
| 04/05/2007 | WO2007038452A1 Process for synthesizing 1,2,4-triazoles |
| 04/05/2007 | WO2007038444A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
| 04/05/2007 | WO2007038435A2 Estriol therapy for autoimmune and neurodegenerative diseases and disorders |
| 04/05/2007 | WO2007038428A2 Prevention and treatment of gastrointestinal and bladder disorders using active vitamin d compounds |
| 04/05/2007 | WO2007038425A2 Anti-viral compouinds |
| 04/05/2007 | WO2007038387A2 Compounds and methods for the treatment of viruses and cancer |
| 04/05/2007 | WO2007038372A1 Phenylethylamine analogs and their use for treating glaucoma |
| 04/05/2007 | WO2007038367A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 04/05/2007 | WO2007038314A2 Fused heterocyclic compounds useful as kinase modulators |
| 04/05/2007 | WO2007038291A1 Black tea polyphenols and uses thereof |
| 04/05/2007 | WO2007038284A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
| 04/05/2007 | WO2007038271A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
| 04/05/2007 | WO2007038250A2 1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use thereof |
| 04/05/2007 | WO2007038249A2 Ultrasonic concentration of carrier particles |
| 04/05/2007 | WO2007038243A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof |
| 04/05/2007 | WO2007038215A1 Tetracyclic inhibitors of janus kinases |
| 04/05/2007 | WO2007038212A1 ADENOSINE A2a RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS |
| 04/05/2007 | WO2007038201A1 Methylene blue therapy of parasitic infections |
| 04/05/2007 | WO2007038110A2 Trans-lutein xantophyllester of high purity and bioavailability in micellar solution |
| 04/05/2007 | WO2007038094A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3 |
| 04/05/2007 | WO2007038092A1 Combination methods for preserving visual acuity |
| 04/05/2007 | WO2007038074A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 04/05/2007 | WO2007038073A2 Mutations and polymorphisms of hdac11 |
| 04/05/2007 | WO2007038058A2 Amino-aza-adamantane derivatives and methods of use |
| 04/05/2007 | WO2007038045A1 Tetrahydro-indazolyl cannabinoid modulators |